The Exome Sequencing Identified the Mutation in Yars2 Encoding the Mitochondrial Tyrosyl-Trna Synthetase As A Nuclear Modifier for the Phenotypic Manifestation of Leber'S Hereditary Optic Neuropathy-Associated Mitochondrial Dna Mutation

Pingping Jiang,Xiaofen Jin,Yanyan Peng,Meng Wang,Hao Liu,Xiaoling Liu,Zengjun Zhang,Yanchun Ji,Juanjuan Zhang,Min Liang,Fuxin Zhao,Yan-Hong Sun,Minglian Zhang,Xiangtian Zhou,Ye Chen,Jun Qin Mo,Taosheng Huang,Jia Qu,Min-Xin Guan
DOI: https://doi.org/10.1093/hmg/ddv498
IF: 5.1214
2016-01-01
Human Molecular Genetics
Abstract:Leber's hereditary optic neuropathy (LHON) is the most common mitochondrial disorder. Nuclear modifier genes are proposed to modify the phenotypic expression of LHON-associated mitochondrial DNA (mtDNA) mutations. By using an exome sequencing approach, we identified a LHON susceptibility allele (c.572G>T, p.191Gly>Val) in YARS2 gene encoding mitochondrial tyrosyl-tRNA synthetase, which interacts with m.11778G>A mutation to cause visual failure. We performed functional assays by using lymphoblastoid cell lines derived from members of Chinese families (asymptomatic individuals carrying m.11778G>A mutation, or both m.11778G>A and heterozygous p.191Gly>Val mutations and symptomatic subjects harboring m.11778G>A and homozygous p.191Gly>Val mutations) and controls lacking these mutations. The 191Gly>Val mutation reduced the YARS2 protein level in the mutant cells. The aminoacylated efficiency and steady-state level of tRNA(Tyr) were markedly decreased in the cell lines derived from patients both carrying homozygous YARS2 p.191Gly>Val and m.11778G>A mutations. The failure in tRNATyr metabolism impaired mitochondrial translation, especially for polypeptides with high content of tyrosine codon such as ND4, ND5, ND6 andCOX2 in cells lines carrying homozygous YARS2 p.191Gly>Val and m.11778G>A mutations. The YARS2 p.191Gly>Val mutation worsened the respiratory phenotypes associated with m.11778G>A mutation, especially reducing activities of complexes I and IV. The respiratory deficiency altered the efficiency of mitochondrial ATP synthesis and increased the production of reactive oxygen species. Thus, mutated YARS2 aggravates mitochondrial dysfunctions associated with the m.11778G>A mutation, exceeding the threshold for the expression of blindness phenotype. Our findings provided new insights into the pathophysiology of LHON that were manifested by interaction between mtDNA mutation and mutated nuclear-modifier YARS2.
What problem does this paper attempt to address?